Income Taxes |
9 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Income Tax Disclosure [Abstract] | |
| Income Taxes | Income Taxes Income tax expense was $9,242 and $12,999 in the three and nine months ended December 31, 2025, respectively, compared to income tax expense of $4,085 and $7,307 in the three and nine months ended December 31, 2024, respectively. The change in income tax expense compared to the prior year period relates primarily to current federal taxes driven by an increase in pre-tax income projections. The One Big Beautiful Bill Act (the “OBBBA”), enacted on July 4, 2025, includes several corporate tax provisions relevant to U.S. businesses. Included in this legislation are provisions that allow for the immediate expensing of domestic research and development expenses, extensions of bonus depreciation, and modifications to the international tax regimes. The provisions in the legislation are generally effective beginning in our fiscal 2026. The Company is continuing to evaluate the impact of these provisions on its financial statements, but an estimate of the financial impact has been included in our operating results for the three and nine months ended December 31, 2025. The OBBBA did not have a material impact to our income tax provision for the three and nine months ended December 31, 2025. |